Bharat Biotech Launches New Cost-Effective Rotavirus Vaccine ‘ROTAVAC 5D’
An official press release from Bharat Biotech said that the vaccine named ‘ROTAVAC 5D’ has been evaluated in clinical trials in India and other countries. It is safe, effective and affordable, besides being cross-protective against a variety of rotavirus strains. The study results showed clear evidence of protection across different rotavirus strains and continued efficacy in the second year of life. Currently, over 25 countries have granted patents for it.